spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

ERT Launches the Industrys First Multi-Language Diagnostic Platform for Respiratory Trials

ERT

Native language capabilities significantly improve site performance and clinical data quality

PHILADELPHIA – December 5, 2016 –– ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced a significant enhancement to MasterScope™, the company’s flagship platform for centralized respiratory clinical trials, making it the industry’s first and only multi-language solution.

With multi-language capabilities, MasterScope enables sites to manage respiratory trials in their native language, which saves time, reduces the risk of protocol compliance errors, and improves overall data quality. Sponsors can now confidently expand the scope of countries in their trials, removing language as a barrier to site performance.

“Respiratory trials are highly complex, requiring investigative site personnel to guide patients through precise maneuvers in order to collect accurate data that supports drug efficacy and safety claims,” said Achim Schülke, Executive Vice President, Respiratory Solutions at ERT. “Assuming all site personnel and patients can comprehend English well enough to accurately follow these workflows is impractical. With these enhancements to MasterScope, sponsors running global cardiopulmonary trials can now add native language capabilities to reduce another level of risk while increasing site compliance.”

ERT’s MasterScope supports any clinical trial that requires spirometry measurements, including those that also collect Fractional exhaled Nitric Oxide (FeNO), electrocardiogram (ECG), home spirometry, and electronic Clinical Outcome Assessment (eCOA) data.

For more information on ERT’s suite of Respiratory Solutions, visit http://www.ert.com/respiratory.
phone +1 800 961 5004
email eresearch@ert.com
web www.ert.com
email 1818 Market Street, Suite 1000, Philadelphia, PA 19103
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Rentschler Biotechnologie GmbH Announces Transition into a European Corporation Called Rentschler Biopharma SE


More info >>


White Papers

The EC Definition of a Nanomaterial - Potential Measurement Methodologies

NanoSight

In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.
More info >>

Industry Events

Pharmaceutical Microbiology East Coast

13-14 November 2017, Renaissance Woodbridge Hotel, New Jersey

Drawing on from the huge success of SMi’s Pharmaceutical Microbiology event series, SMi is delighted to announce the launch of Pharmaceutical Microbiology East Coast. Being the eighth in its series, this event will take place in New Jersey, USA, on November 13th and 14th 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology East Coast 2017 will address the best practices for rapid microbial and sterility testing and tackle the challenges of contamination control.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement